companydata.dkcompanydata.dk

MC2 Therapeutics A/S: Financial statements 2018

CVR: 29526346

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

MC2 Therapeutics A/S (CVR 29526346) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 13,340,000 and a net result of DKK -110,067,000 compared with DKK -79,128,188 the year before. That is an increase of 30.1% compared with the year before. Equity in the 2018 report amounted to DKK 62,254,000. The solvency ratio was 83.7%. The company had 10 employees in the financial year.

Gross Profit
DKK 13,340,000
Profit/Loss
DKK -110,067,000
Equity
DKK 62,254,000
Total Assets
DKK 74,367,000
Employees
10

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-13.3 mio.-110.1 mio.62.3 mio.10
2017-10.3 mio.-79.1 mio.30.9 mio.8
2016-6.8 mio.-40.1 mio.54.4 mio.5
2015-5.4 mio.-24.5 mio.43.4 mio.4
2014-5.6 mio.-19.8 mio.35.4 mio.4

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

MC2 HOLDING ApS registered as owner of MC2 Therapeutics A/SJun 18, 2018

As of June 18, 2018, MC2 HOLDING ApS is registered as an owner of MC2 Therapeutics A/S with an ownership share of 15%.

MC2 Therapeutics A/S: The 2017 annual report is outJun 13, 2018

MC2 Therapeutics A/S has published its annual report for 2017. Gross profit came to DKK 10,252,025, and the net result was DKK -79,128,188.

About MC2 Therapeutics A/S

MC2 Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named MC2 Therapeutics ApS and MC2 BIOTEK ApS. The management consists of Trine Ahlgreen. The board consists of Mads Jørgen Nøhr Clausen (chair), Anders Dahlgaard Hove, John Sørensen Haurum and Tomas Dahl Mikkelsen. The company is owned by Alsmark Invest II ApS, MC2 HOLDING ApS and Selskabet af 4. april 2023 ApS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 22,248,504 and a net result of DKK -7,816,954 compared with DKK -53,006,931 the year before. Equity in the 2025 report amounted to DKK -224,478,927.

Source: annual report 2025, Danish Business Authority